We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Stereotactic Radiosurgery Useful in Eliminating Parkinson's Disease Tremors

By HospiMedica International staff writers
Posted on 16 Nov 2009
Stereotactic radiosurgery (SRS) offers a less invasive, and just as effective, option to eliminate tremors caused by Parkinson's disease and essential tremor than deep brain stimulation (DBS) and radiofrequency (RF) treatments.

Researchers at the Joe Arrington Cancer Center (Lubbock, TX, USA) and Texas Tech University (Lubbock, TX, USA) followed 183 patients who underwent SRS thalamotomy between 1991 and 2007, for hard-to-treat tremors caused by Parkinson's disease and essential tremors. More...
With a median follow-up of seven years, 84% of the patients had significant or complete resolution of tremors. In patients with Parkinson's disease, 83% had near or complete tremor resolution, while those with essential tremor had 87% of this degree of tremor resolution. The study was presented at the 51st annual meeting of the American Society for Radiation Oncology (ASTRO), held during November 2009 in Chicago (IL, USA).

"The study shows that radiosurgery is an effective and safe method of getting rid of tremors caused by Parkinson's disease and essential tremor, with outcomes that favorably compare to both DBS and RF in tremor relief and risk of complications at seven years after treatment,” said study coauthor radiation oncologist Rufus Mark, M.D. "In view of these long-term results, this noninvasive procedure should be considered a primary treatment option for tremors that are hard to treat.”

Thalamotomy is an invasive procedure, primarily effective for tremors such as those associated with Parkinson's disease (PD), where a selected portion of the thalamus, the Ventralis Inter-Medius nucleus, is surgically destroyed or ablated. Neurosurgeons use specialized equipment to precisely locate an area of the thalamus, usually choosing to work on only one side (the side opposite that of the worst tremors). Bilateral procedures are poorly tolerated because of increased complication and risk, including vision and speech problems. The positive effects on tremor are immediate. Other less destructive procedures, such as subthalamic DBS, are sometimes preferred, since this procedure can also improve other symptoms of PD.


Related Links:
Joe Arrington Cancer Center

Texas Tech University




Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.